Objectives: Laboratory tests are usually requested for monitoring during outpatient parenteral antimicrobial therapy (OPAT), but these recommendations are not always followed. The purpose of this study was to determine whether rehospitalization during the OPATcourse is associated with the availability of these test results to the treating physician.
Introduction
The outpatient parenteral antimicrobial therapy (OPAT) programme at the Cleveland Clinic has existed since November 1979 and the programme now encompasses 3500 OPAT courses yearly. 1 The OPAT programme is a team effort of physicians, nurses, case managers and pharmacists. An infectious disease (ID) physician is consulted for every patient who is under evaluation for discharge with parenteral antimicrobial therapy. If OPAT is indicated, patients are discharged to home-based care, a skilled nursing facility (SNF) or a long-term acute care (LTAC) facility based on patient preference, insurance coverage and the need for inpatient rehabilitation or skilled care. Geographical conditions preclude having patients return to a hospital-based infusion centre daily for administration of antimicrobial therapy. The ID physician prescribes the antimicrobial regimen, route of administration, dose and duration, recommends necessary monitoring laboratory tests and establishes an outpatient follow-up appointment for the patient. An OPATstart form is created in the electronic health record (EHR) detailing this information and this form is forwarded to the appropriate OPAT agency. 1 The advantages of OPAT are that the complex management of patients needing parenteral antimicrobial therapy can be done outside the hospital, reducing the overall length of hospital stay, thereby reducing healthcare costs, avoiding hospital-acquired complications, such as nosocomial infections, and reducing patient inconvenience. 1 -3 The OPAT process carries an inherent risk of adverse outcomes, including worsening of the infection, antimicrobial adverse events and vascular access complications. 1 Some of these adverse outcomes result in rehospitalization. Readmission rates for patients on OPAT have ranged from 6% to 50% in past studies, varying with type of infection and duration of follow-up. 4 -7 In one study of complications of OPAT, leucopenia, neutropenia, eosinophilia, thrombocytopenia, nephrotoxicity, diarrhoea, rash and vascular access problems were the most common complications. 8 Recognition of the potential for adverse events is reflected in recommendations in the USA and the UK to monitor patients on OPAT for laboratory test result abnormalities. 9, 10 Laboratory tests are recommended to be performed weekly or biweekly for most OPAT courses, with the expectation that the results will be made available to the treating physicians.
Although laboratory tests are routinely recommended for monitoring, the results are not always available to the treating physician. When a patient is discharged from hospital, care is usually transitioned from one healthcare institution (hospital) to another (home health agency, SNF or LTAC facility). Practising physicians are acutely aware of challenges in getting data for patients when transitioned from one healthcare delivery setting to another. Nonavailability of the recommended test results may be due to a lack of adherence to recommendations or a lack of effective communication between the different healthcare entities involved. Since most patients complete their OPAT courses without any adverse events occurring, the importance of following test monitoring recommendations and getting the results to the treating physician may not be adequately appreciated. However, it should be expected that poor monitoring has the potential to lead to adverse outcomes. If inadequate monitoring can be shown to be associated with poor outcomes, there would be good scientific rationale for strongly emphasizing adherence to laboratory test monitoring recommendations and timely communication to get the results to the treating physicians. Having outcome data to support practice recommendations such as laboratory test monitoring during OPAT will become increasingly important in the environment of the Affordable Care Act.
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The aim of this study was to determine whether availability of the recommended test results to treating physicians is associated with hospital readmission while on OPAT.
Methods
This was a retrospective cohort study of patients discharged from hospital on OPAT from a single large tertiary care centre between 1 January and 28 February 2011.
Study population
All patients discharged from Cleveland Clinic on parenteral antimicrobials are evaluated by an ID physician before discharge from hospital. 1 Since July 2007, there has been a mandatory requirement for filling out a structured data entry form in the EHR for every patient for whom post-discharge parenteral antimicrobial therapy is planned. The data entered into the structured data entry form are available in the Cleveland Clinic OPATregistry.
Patients were identified from the Cleveland Clinic OPAT registry. Manual review of the EHR for these identified patients was performed to exclude patients who did not leave the hospital on parenteral antimicrobials. Patients discharged to another hospital were excluded. For patients who received more than one OPAT course, only the first course was included. Patients who died while on OPAT were excluded, as death would be a competing outcome for the primary outcome of the study.
Data sources and data extraction
Variables available in the OPAT registry included patient age, sex, race, anticipated OPAT end date, parenteral antimicrobial(s), the diagnosis being treated with the parenteral antimicrobial(s) and monitoring laboratory test recommendations. These data were supplemented with data abstracted by manual review of the EHR, which included the dates of hospitalization and discharge (the discharge date was considered the OPAT start date), the OPAT administration site (home, SNF, LTAC or dialysis centre), the actual OPATend date, the reason for OPATend and the availability of laboratory test results recommended for monitoring. The patients were followed until the actual OPAT end date. For those where the actual OPAT end date was not known (patients whose care was assumed by outside physicians), patients were followed until the anticipated OPAT end date outlined in the OPAT start-of-care form. Investigators (D. H. and J. P. G.) reviewed the EHR for relevant data with guidance from ID physicians (S. M. G. and N. K. S.) who manage OPATpatients. The first author reviewed all courses a second time to verify accuracy.
Study definitions
Availability of the recommended test results was defined as having the results documented in the EHR. The results of all tests done within the Cleveland Clinic Health System laboratories are automatically uploaded into the health system's EHR. All faxed, phoned or mailed test results from outside laboratories for patients receiving OPATare entered into the EHR by a clinical assistant as a standard part of the OPAT programme. The lack of laboratory test results in the EHR meant the results were not available to the treating physician. The recommended laboratory tests varied with the antimicrobial therapy prescribed and included (by percentage of OPAT courses in which they were recommended) complete blood counts (98%), serum creatinine (97%), antibiotic levels (41%), C-reactive protein (17%), liver function tests (15%), creatine kinase (7%), erythrocyte sedimentation rate (ESR) (6%) or serum electrolyte levels (3%). These were typically recommended either weekly or biweekly. Test result availability was categorized for each week of the OPATcourse as available (at least one recommended test result documented) or non-available (no recommended test result documented). With respect to test result availability, patients were grouped into the following categories: (i) non-available, defined as test results 'non-available' for all weeks; and (ii) available, defined as test results available for ≥1 week.
Outcomes and statistical methods
The primary outcome was hospital readmission while on OPAT. Actual OPAT duration, proportion seen at an ID follow-up office visit and premature discontinuation of OPAT due to antimicrobial adverse events were also compared among patients with and without test results available. The baseline characteristics and outcomes for patients with and without test results available were compared using Pearson's x 2 test or Fisher's exact test for categorical variables and Student's t-test (mean values) or Mann-Whitney U-test (median values) for continuous variables. Logistic regression modelling was used to explore the association between laboratory test result availability and hospital readmission. Adjustments were made for OPAT characteristics and patient demographics that were associated with readmission or laboratory test result availability in univariable analysis including patient age, hospital length of stay (LOS), anticipated OPAT duration, OPAT site and Charlson comorbidity index score. The Charlson score is a commonly used measure of comorbidity and was calculated based on the comorbid condition scoring scheme previously described.
12 JMP 10.0 software (SAS Institute, Cary, NC, USA) was used for all statistical analyses.
Results
From the 523 OPAT courses in the OPAT registry during the study period, 408 (443 OPAT courses) patients were identified who were discharged from hospital on parenteral antibiotics. After excluding patients discharged to other hospitals or those who died during OPAT, 400 patients were identified who received at least one OPAT laboratory results and rehospitalizations 229 JAC course of OPAT (Figure 1 ). Of the 400 included OPAT courses, 60% were OPAT courses administered at home, 36% in SNF or LTAC facilities and 4% in other settings. Test results were 'available' in 291 (73%) patients.
Baseline characteristics and associations with test result availability
The baseline patient demographic and clinical characteristics of OPATcourses with test results available and non-available are compared in Table 1 . Non-availability of the test results was associated with older patient age, longer pre-OPAT hospital LOS, shorter anticipated OPATduration, increasing Charlson score and cardiovascular infection. In addition, only 71 of 144 (49%) OPATcourses at an SNF/ LTAC facility had test results available compared with 213 of 238 (89%) OPATcourses at home (P,0.001). The most common infecting microorganisms included Staphylococcus aureus (20%), Enterobacteriaceae (15%), coagulase-negative Staphylococcus (9%), Enterococcus (9%), Pseudomonas aeruginosa (6%), Streptococcus spp. (6%) and Candida (6%). The most common antimicrobials used included vancomycin (33%), b-lactam antibiotics (27%), carbapenems (12%), cephalosporins (11%), antifungals (6%) and daptomycin (5%). No significant associations between infecting microorganism or antimicrobial and test result availability were found except for a higher percentage of Enterococcus infections when test results were not available (15% compared with 6%). Detailed stratification by infecting microorganism and antimicrobial prescribed was not done in Table 1 for the sake of readability.
Outcomes
The outcomes for the patients with and without test results available are compared in Table 2 . Overall, 82 patients (20.5%) were readmitted while on therapy. The proportion of patients readmitted while on OPAT was significantly higher in the group with test results non-available. Actual OPAT duration was shorter for patients with test results non-available and the proportion seen in follow-up in the ID clinic was lower. Significantly fewer patients with test results non-available had their parenteral antimicrobial prematurely stopped for an adverse effect.
Readmissions during OPAT
Associations of important demographic and clinical factors with readmission during OPAT in a univariable (unadjusted) and multivariable (adjusted) logistic regression model are presented in Table 3 . Test result non-availability was independently associated with readmission while on OPAT (adjusted OR 2.53; 95% CI Huck et al. Charlson comorbidity index score was calculated based on the comorbid condition scoring scheme previously described. 12 OPAT laboratory results and rehospitalizations 231 JAC OPAT agency/site and the Cleveland Clinic OPAT programme. Poor post-discharge communication has been associated with higher rates of readmission in a number of other studies. 13 -15 This study has several limitations. Its retrospective design limits information to what was documented in the EHR. Some readmissions may not have been documented. The Cleveland Clinic uses an integrated EHR across its health system and thus all readmissions, not just to Cleveland Clinic hospital but to the entire health system, would have been captured. Nevertheless, readmissions outside the Cleveland Clinic Health System may have been missed. However, poor documentation of readmission would have more likely occurred in otherwise poorly documented courses, such as courses with non-available recommended laboratory test results. This study would thus be expected to have underestimated the magnitude of the association of nonavailability of laboratory test results and readmission. A further limitation of this study is that the availability of laboratory test results was stratified into only two levels: totally non-available and available during any week. The variability in the duration of OPAT and sample size limitations precluded stratification into multiple groups. This stratification is extremely conservative (as it needed only one laboratory result to be reported to be considered available) and one could expect this to underestimate the impact that complete availability would have on readmission. The need for extensive individual chart review limited the overall sample size of this study.
The overall readmission rate during the OPAT course of 20.5% found in this study is comparable to the Medicare 30 day Test results available during ≥1 week of the OPAT course (reference). c Charlson comorbidity index score was calculated based on the comorbid condition scoring scheme previously described. 12 Huck et al.
readmission rate of 19.6%. 16 This readmission rate is also in the midrange of those found in previous studies of OPAT outcomes, which were as low as 6% in patients with skin and soft tissue infections 4 and as high as 50% in patients with prosthetic joint infections.
